Neuroblastoma (NB) originates in the adrenal medulla or the sympathetic neural chains and accounts for 9–10 % of all pediatric tumors. The familial form of NB is rare, accounting for 1 % of all NB. Wilms tumor (WT) is an embryonic kidney cancer and constitutes 5 % of all pediatric tumors. The incidence of hereditary cases is suggested to be about 1–3 %. The hereditary form in both tumors is supposed to be autosomal dominant with inconsistent penetrance. The first candidate gene found in an American NB family pedigree was 16p12–13, and 4p16 or 4p12 was later suggested in an Italian NB family. Recently, the synergic action of 2p and 12p abnormality was also suggested to be the cause of familial occurrence. In WT, two types of cancer suppressor genes,
WT1 and
WT2, were identified. Congenital absence of
WT1 is characterized by the association of aniridia or urogenital abnormalities. However, cases of WT familial occurrence are not always associated with such somatic abnormalities. Recently, new loci of 17q12–21 or 19q13 have been also suggested as causes of familial occurrence but these genes are not considered tumor suppressor genes. These findings suggest that tumor occurrence is a multifactorial event and tumor heterogeneity is apparent from the study of hereditary occurrence in NB or WT.
View full abstract